BridgeMD
Tests treatment safety and results for Enhanced Recovery After Surgery
Official title Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy
ClinicalTrials.gov ID: NCT06984952
What this study is testing
- What it's testing
- This prospective, randomized, open-label, multicenter study is designed to evaluate the impact of an enhanced recovery after surgery (ERAS) protocol on the rate of meeting discharge criteria in patients undergoing minimally-invasive gastrectomy for gastric cancer. We hypothesize that implementation of our ERAS protocol will significantly increase the proportion of patients who meet standardized discharge criteria following minimally-invasive gastrectomy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Adults aged ≥19 years scheduled to undergo elective laparoscopic or robotic gastrectomy for gastric cancer
- American Society of Anesthesiologists physical status classification I to III
- Ability to provide written informed consent, demonstrate understanding of the study protocol, and complete patient-reported outcome measures...
You likely can't join if
- Requirement for resection of organs other than the stomach during surgery (except for cholecystectomy)
- History of upper abdominal surgery (except for cholecystectomy)
- Known hypersensitivity to fentanyl, ropivacaine, acetaminophen, or non-steroidal anti-inflammatory drugs
- Determined by the investigator or study personnel to be otherwise unsuitable for participation in the study
The study team makes the final eligibility decision.
Where it's taking place
- Busan, South Korea
- Daegu, South Korea
- Daejeon, South Korea
- Goyang, South Korea
- Seongnam, South Korea
- Seoul, South Korea
- Suwon, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Busan, South Korea; Daegu, South Korea; Daejeon, South Korea; Goyang, South Korea; Seongnam, South Korea; Seoul, South Korea and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.